Page 207 - MSU Digital Book

30. Dipiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V. Pharmacotherapy:

a pathophysiologic approach. 11th edition. Ohio: McGraw-Hill; 2020.
31. Matzke GR, Aronoff GR, Atkinson AJ Jr, Bennett WM, Decker BS, Eckardt KU, et al.
Drug dosing consideration in patients with acute and chronic kidney disease-a

clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney
Int. 2011;80:1122-37.

32. Saad R, Hallit S, Chahine B. Evaluation of renal drug dosing adjustment in
chronic kidney disease patients at two university hospitals in Lebanon. Pharm Pract
(Granada). 2019;17:1304.

33. Solak Y, Biyik Z, Gaipov A, Kayrak M, Ciray H, Cizmecioglu A, et al. Drug dose
adjustment in dialysis patients admitted in clinics other than internal medicine.

Am J Ther. 2016;23:e68-73.
34. Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R. Impact of a renal drug dosing service
on dose adjustment in hospitalized patients with chronic kidney disease. Ann

Pharmacother. 2009;43:1598-605.
35. Jiang SP, Xu YY, Ping-Yang, Wu WF, Zhang XG, Lu XY, et al. Improving antimicrobial

dosing in critically ill patients receiving continuous venovenous hemofiltration and
the effect of pharmacist dosing adjustment. Eur J Intern Med. 2014;25:930-5.
36. Jiang SP, Zhu ZY, Wu XL, Lu XY, Zhang XG, Wu BH. Effectiveness of pharmacist

dosing adjustment for critically ill patients receiving continuous renal replacement
therapy: a comparative study. Ther Clin Risk Manag. 2014;10:405-12.

37. Jiang SP, Zhu ZY, Ma KF, Zheng X, Lu XY. Impact of pharmacist antimicrobial
dosing adjustments in septic patients on continuous renal replacement therapy in
an intensive care unit. Scand J Infect Dis. 2013;45:891-9.

182